TrialAntimicrobial agents and chemotherapy2020

Outcomes in Participants with Renal Impairment from a Phase 3 Clinical Trial for Ceftolozane/Tazobactam Treatment of Nosocomial Pneumonia (ASPECT-NP).

Jennifer A Huntington et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.